This observation illustrates the superior nature of CETN1 as the target, which facilitate the majority of the radioimmunoconjugate concentrating in the PDAC tumor site; due to the high specificity of the antibody as well as the exclusive accessibility of CETN1 antigen within the PDAC microenvironment. The gene discussed is CETN1; the disease is neoplasm.